{
  "context": {
    "rules": [
      "Rule1: Provided that Legislation Delta grants fast track status to Drug X, if it is not the case that Drug X is authorized for emergency use in Region Alpha or Drug X meets the standards of Organization Gamma, then Drug X does not have standard approval in Region Alpha.",
      "Rule2: In the event that Legislation Delta grants priority review to Drug X, if neither emergency use authorization in Region Alpha nor meeting the standards of Organization Gamma occurs, then Drug X lacks standard approval in Region Alpha.",
      "Rule3: Whenever Legislation Delta grants breakthrough designation to Drug X, it follows that Legislation Delta grants fast track status to Drug X.",
      "Rule4: Should Legislation Delta grant accelerated approval to Drug X, then Legislation Delta grants priority review to Drug X.",
      "Rule5: Either Legislation Delta follows the traditional pathway for Drug X, or Legislation Delta grants breakthrough designation to Drug X, or Legislation Delta grants accelerated approval to Drug X.",
      "Rule6: Given that Organization Gamma has production certification for Drug X, Organization Gamma also has quality approval for Drug X.",
      "Rule7: Assuming Drug X is banned in Region Beta, if Drug X does not meet the standards of Organization Gamma, then Drug X is not approved in Region Alpha.",
      "Rule8: Provided that Organization Gamma has quality approval for Drug X, Organization Gamma has manufacturing approval for Drug X.",
      "Rule9: In the case that Legislation Delta grants a special exemption for Drug X, if it is not true that compliance of Organization Gamma with Legislation Delta implies that testing by Organization Gamma leads to Drug X meeting standards, then Legislation Delta does not grant a regulatory waiver for Drug X.",
      "Rule10: Whenever Legislation Delta grants exceptional approval for Drug X, if the condition that compliance of Organization Gamma with Legislation Delta ensures that testing by Organization Gamma results in Drug X meeting standards is false, then Legislation Delta does not grant a regulatory waiver for Drug X.",
      "Rule11: If Legislation Delta follows the normal process for Drug X, then Legislation Delta follows standard procedure for Drug X.",
      "Rule12: Provided that Drug X has interim approval in Region Alpha, Drug X has preliminary approval in Region Alpha.",
      "Rule13: In the event that Drug X has provisional approval in Region Alpha, Drug X has interim approval in Region Alpha.",
      "Rule14: If Drug X has conflicting status in Region Alpha, then Drug X has approved status in Region Alpha.",
      "Rule15: Either Drug X has conflicting status in Region Alpha, or if Drug X has temporary approval in Region Alpha, then Drug X has conditional approval in Region Alpha.",
      "Rule16: In the case that Drug X is in clinical trial with Organization Gamma, Drug X is safety-approved by Organization Gamma.",
      "Rule17: Should Drug X be safety-approved by Organization Gamma, then Drug X is efficacy-approved by Organization Gamma.",
      "Rule18: Given that Drug X is efficacy-approved by Organization Gamma, Drug X does not have market access in Region Alpha.",
      "Rule19: Provided that neither a special exemption nor exceptional approval is granted by Legislation Delta for Drug X, Legislation Delta follows the normal process for Drug X.",
      "Rule20: In the event that it is not true that conflicting status of Drug X in Region Alpha implies no approved status, then Drug X has resolved status in Region Alpha.",
      "Rule21: Should the condition that compliance of Organization Gamma with Legislation Delta ensures that testing by Organization Gamma results in Drug X meeting standards be false, then Legislation Delta grants a regulatory waiver for Drug X.",
      "Rule22: If it is not the case that compliance of Organization Gamma with Legislation Delta implies that testing by Organization Gamma leads to Drug X meeting standards, then Drug X has market access in Region Alpha.",
      "Rule23: Provided that the implication from compliance of Organization Gamma with Legislation Delta to testing resulting in Drug X meeting standards is false, Drug X is in clinical trial with Organization Gamma.",
      "Rule24: If neither emergency use authorization in Region Alpha nor meeting the standards of Organization Gamma occurs, then Drug X has standard approval in Region Alpha.",
      "Rule25: If it is not the case that Drug X is authorized for emergency use in Region Alpha or meets the standards of Organization Gamma, then Drug X does not have preliminary approval in Region Alpha.",
      "Rule26: Provided that the failure of lacking emergency use authorization or meeting standards to imply provisional approval holds, then Drug X has final approval in Region Alpha.",
      "Rule27: In the case that the condition of not meeting standards not implying conditional approval is met, then Drug X has full approval in Region Alpha.",
      "Rule28: If it is not true that not meeting the standards implies no approval for Drug X, then Organization Gamma has production certification for Drug X.",
      "Rule29: Whenever Drug X does not meet the standards of Organization Gamma, Drug X is approved in Region Alpha.",
      "Rule30: In the event that Drug X does not meet the standards of Organization Gamma, Drug X has temporary approval in Region Alpha."
    ],
    "facts": [
      "Fact1: Drug X is banned in Region Beta.",
      "Fact2: Drug X is tested by Organization Gamma.",
      "Fact3: Organization Gamma is compliant with Legislation Delta.",
      "Fact4: It is not the case that Legislation Delta follows the traditional pathway for Drug X.",
      "Fact5: Drug X does not have conditional approval in Region Alpha.",
      "Fact6: Drug X does not have full approval in Region Alpha.",
      "Fact7: Organization Gamma does not have manufacturing approval for Drug X.",
      "Fact8: Legislation Delta does not follow standard procedure for Drug X.",
      "Fact9: Drug X does not have final approval in Region Alpha.",
      "Fact10: Drug X does not have resolved status in Region Alpha.",
      "Fact11: Drug X is not authorized for emergency use in Region Alpha."
    ]
  },
  "question": "Drug X meets the standards of Organization Gamma."
}